Niemann-pick c1 mice, a model of "juvenile alzheimer's disease", with normal gene expression in neurons and fibrillary astrocytes show long term survival and delayed neurodegeneration

Ivan Borbon, John Totenhagen, Maria Teresa Fiorenza, Sonia Canterini, Wangjing Ke, Theodore Trouard, Robert P. Erickson

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

Niemann-Pick C1 (NPC) disease, also known as "juvenile Alzheimer's disease", is a disease in which alterations in intracellular cholesterol trafficking occur. The contribution of various CNS cell types to the neurodegeneration has been of much interest. We have previously shown that expression of the normal gene only in fibrillary astrocytes could extend survival of Npc1-/- mice over 3-fold (Zhang et al., 2008 [13]). We have now studied expression only in neurons or in both neurons and fibrillary astrocytes. Neuron-only expression resulted in survivals of over a year (>5-fold) but motor symptoms started at about 6 months. As reflected in weight gain, this especially affected females who weighed less than wild-type starting at about 10 weeks while male differences in weight are delayed. Expression in both cell types led to a nearly normal phenotype with motor symptoms developing at about ten months and increased survival times. Purkinje cell loss was slowed, but severe, in both NSE-and NSE-GFAP-Npc1, transgenic Npc1-/- mice. MRI studies showed that myelination of the long tracts was significantly improved in NSE-Npc1 transgenics, perhaps less than in GFAP-Npc1 transgenics, and not differently than in the double transgenics. Memory was improved in both single and double transgenics. Somatic disease had not been ameliorated and lungs were massively infiltrated with foamy macrophages at 10 months. Our results suggest that neuron-only expression does not completely prevent neurodegeneration and that the addition of astrocyte expression decreases the rate/degree of decline.

Original languageEnglish (US)
Pages (from-to)875-887
Number of pages13
JournalJournal of Alzheimer's Disease
Volume30
Issue number4
DOIs
StatePublished - 2012

Fingerprint

Astrocytes
Alzheimer Disease
Gene Expression
Neurons
Niemann-Pick Diseases
Purkinje Cells
Transgenic Mice
Weight Gain
Macrophages
Cholesterol
Phenotype
Weights and Measures
Lung

Keywords

  • Astrocyte-specific gene expression
  • cell autonomy
  • intracellular cholesterol transport
  • neurodegeneration
  • neuron-specific gene expression

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Geriatrics and Gerontology
  • Clinical Psychology

Cite this

Niemann-pick c1 mice, a model of "juvenile alzheimer's disease", with normal gene expression in neurons and fibrillary astrocytes show long term survival and delayed neurodegeneration. / Borbon, Ivan; Totenhagen, John; Fiorenza, Maria Teresa; Canterini, Sonia; Ke, Wangjing; Trouard, Theodore; Erickson, Robert P.

In: Journal of Alzheimer's Disease, Vol. 30, No. 4, 2012, p. 875-887.

Research output: Contribution to journalArticle

Borbon, Ivan ; Totenhagen, John ; Fiorenza, Maria Teresa ; Canterini, Sonia ; Ke, Wangjing ; Trouard, Theodore ; Erickson, Robert P. / Niemann-pick c1 mice, a model of "juvenile alzheimer's disease", with normal gene expression in neurons and fibrillary astrocytes show long term survival and delayed neurodegeneration. In: Journal of Alzheimer's Disease. 2012 ; Vol. 30, No. 4. pp. 875-887.
@article{85adaf15c22c4f56a4d16321d53ca4e7,
title = "Niemann-pick c1 mice, a model of {"}juvenile alzheimer's disease{"}, with normal gene expression in neurons and fibrillary astrocytes show long term survival and delayed neurodegeneration",
abstract = "Niemann-Pick C1 (NPC) disease, also known as {"}juvenile Alzheimer's disease{"}, is a disease in which alterations in intracellular cholesterol trafficking occur. The contribution of various CNS cell types to the neurodegeneration has been of much interest. We have previously shown that expression of the normal gene only in fibrillary astrocytes could extend survival of Npc1-/- mice over 3-fold (Zhang et al., 2008 [13]). We have now studied expression only in neurons or in both neurons and fibrillary astrocytes. Neuron-only expression resulted in survivals of over a year (>5-fold) but motor symptoms started at about 6 months. As reflected in weight gain, this especially affected females who weighed less than wild-type starting at about 10 weeks while male differences in weight are delayed. Expression in both cell types led to a nearly normal phenotype with motor symptoms developing at about ten months and increased survival times. Purkinje cell loss was slowed, but severe, in both NSE-and NSE-GFAP-Npc1, transgenic Npc1-/- mice. MRI studies showed that myelination of the long tracts was significantly improved in NSE-Npc1 transgenics, perhaps less than in GFAP-Npc1 transgenics, and not differently than in the double transgenics. Memory was improved in both single and double transgenics. Somatic disease had not been ameliorated and lungs were massively infiltrated with foamy macrophages at 10 months. Our results suggest that neuron-only expression does not completely prevent neurodegeneration and that the addition of astrocyte expression decreases the rate/degree of decline.",
keywords = "Astrocyte-specific gene expression, cell autonomy, intracellular cholesterol transport, neurodegeneration, neuron-specific gene expression",
author = "Ivan Borbon and John Totenhagen and Fiorenza, {Maria Teresa} and Sonia Canterini and Wangjing Ke and Theodore Trouard and Erickson, {Robert P.}",
year = "2012",
doi = "10.3233/JAD-2012-120199",
language = "English (US)",
volume = "30",
pages = "875--887",
journal = "Journal of Alzheimer's Disease",
issn = "1387-2877",
publisher = "IOS Press",
number = "4",

}

TY - JOUR

T1 - Niemann-pick c1 mice, a model of "juvenile alzheimer's disease", with normal gene expression in neurons and fibrillary astrocytes show long term survival and delayed neurodegeneration

AU - Borbon, Ivan

AU - Totenhagen, John

AU - Fiorenza, Maria Teresa

AU - Canterini, Sonia

AU - Ke, Wangjing

AU - Trouard, Theodore

AU - Erickson, Robert P.

PY - 2012

Y1 - 2012

N2 - Niemann-Pick C1 (NPC) disease, also known as "juvenile Alzheimer's disease", is a disease in which alterations in intracellular cholesterol trafficking occur. The contribution of various CNS cell types to the neurodegeneration has been of much interest. We have previously shown that expression of the normal gene only in fibrillary astrocytes could extend survival of Npc1-/- mice over 3-fold (Zhang et al., 2008 [13]). We have now studied expression only in neurons or in both neurons and fibrillary astrocytes. Neuron-only expression resulted in survivals of over a year (>5-fold) but motor symptoms started at about 6 months. As reflected in weight gain, this especially affected females who weighed less than wild-type starting at about 10 weeks while male differences in weight are delayed. Expression in both cell types led to a nearly normal phenotype with motor symptoms developing at about ten months and increased survival times. Purkinje cell loss was slowed, but severe, in both NSE-and NSE-GFAP-Npc1, transgenic Npc1-/- mice. MRI studies showed that myelination of the long tracts was significantly improved in NSE-Npc1 transgenics, perhaps less than in GFAP-Npc1 transgenics, and not differently than in the double transgenics. Memory was improved in both single and double transgenics. Somatic disease had not been ameliorated and lungs were massively infiltrated with foamy macrophages at 10 months. Our results suggest that neuron-only expression does not completely prevent neurodegeneration and that the addition of astrocyte expression decreases the rate/degree of decline.

AB - Niemann-Pick C1 (NPC) disease, also known as "juvenile Alzheimer's disease", is a disease in which alterations in intracellular cholesterol trafficking occur. The contribution of various CNS cell types to the neurodegeneration has been of much interest. We have previously shown that expression of the normal gene only in fibrillary astrocytes could extend survival of Npc1-/- mice over 3-fold (Zhang et al., 2008 [13]). We have now studied expression only in neurons or in both neurons and fibrillary astrocytes. Neuron-only expression resulted in survivals of over a year (>5-fold) but motor symptoms started at about 6 months. As reflected in weight gain, this especially affected females who weighed less than wild-type starting at about 10 weeks while male differences in weight are delayed. Expression in both cell types led to a nearly normal phenotype with motor symptoms developing at about ten months and increased survival times. Purkinje cell loss was slowed, but severe, in both NSE-and NSE-GFAP-Npc1, transgenic Npc1-/- mice. MRI studies showed that myelination of the long tracts was significantly improved in NSE-Npc1 transgenics, perhaps less than in GFAP-Npc1 transgenics, and not differently than in the double transgenics. Memory was improved in both single and double transgenics. Somatic disease had not been ameliorated and lungs were massively infiltrated with foamy macrophages at 10 months. Our results suggest that neuron-only expression does not completely prevent neurodegeneration and that the addition of astrocyte expression decreases the rate/degree of decline.

KW - Astrocyte-specific gene expression

KW - cell autonomy

KW - intracellular cholesterol transport

KW - neurodegeneration

KW - neuron-specific gene expression

UR - http://www.scopus.com/inward/record.url?scp=84863005612&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84863005612&partnerID=8YFLogxK

U2 - 10.3233/JAD-2012-120199

DO - 10.3233/JAD-2012-120199

M3 - Article

C2 - 22495346

AN - SCOPUS:84863005612

VL - 30

SP - 875

EP - 887

JO - Journal of Alzheimer's Disease

JF - Journal of Alzheimer's Disease

SN - 1387-2877

IS - 4

ER -